242 results
Page 2 of 13
8-K
EX-99.2
gmsi0phjdjfqmq9w
15 Aug 22
TherapeuticsMD Announces Second Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
699a1ynq
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-10.1
a4rwbvjd408
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-10.2
px4cgjgkl8dga 3iti
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
9mejbr
29 Jul 22
Entry into a Material Definitive Agreement
8:58am
8-K
esi2m2t
28 Jul 22
Entry into a Material Definitive Agreement
9:47am
8-K
7a9rcfu1
25 Jul 22
Entry into a Material Definitive Agreement
8:00am
8-K
fm3hmv2
14 Jul 22
Entry into a Material Definitive Agreement
9:00am
SC 14D9
EX-99
7re0an 4fwap0armxf75
10 Jun 22
Tender offer solicitation
6:51pm
8-K
EX-2.1
2ibq726qktsz 86mxi9
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-10.2
7q0z0vl
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-99.1
4vzt8 r6gs2y
20 May 22
Regulation FD Disclosure
10:30am
8-K
EX-99.2
uus w3asulukd8jl
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
s67kjxq92 6zefhy
16 May 22
TherapeuticsMD Announces First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
xp4h8uq
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
POS AM
zriis9vu2gh1wq0
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm
POSASR
m5nigqacbgzzn um4
23 Mar 22
Automatic shelf registration (post-effective amendment)
4:37pm